KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced the results from two pivotal Phase 3 trials (COUGH-1 and COUGH-2) evaluating the ...
Mirtazapine (Zipdep (45 mg)) is an antidepressant, prescribed for depression. It alters the activity of certain chemicals in the brain to maintain mental balance. The information provided on this page ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback